Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Journal of Medical Case Reports|September 3, 2018
Continuous infusion of lipo-prostaglandin E1 for Takayasu's arteritis with heart failure in an 11-month-old baby: a case reportRyo Higaki, Aya Miyazaki, Yujiro Tajiri, et al.Frontiers in Immunology|March 13, 2026
Alleviation of experimental arthritis in SKG mice through <i>Nr4a1</i> agonizationYoichi Nakayama, Ryosuke Hiwa, Ayaka Okubo, et al.Rheumatology (Oxford, England)|August 26, 2023
Prediction model for respiratory-related mortality in microscopic polyangiitis with interstitial lung disease: multicentre REVEAL cohort studyShogo Matsuda, Takuya Kotani, Ayana Okazaki, et al.Arthritis Research & Therapy|November 21, 2023
Risk prediction model for mortality in microscopic polyangiitis: multicentre REVEAL cohort studyTakuya Kotani, Shogo Matsuda, Ayana Okazaki, et al.Frontiers in Immunology|February 4, 2025
Identification of novel clinical subtypes in patients with microscopic polyangiitis using cluster analysis: multicenter REVEAL cohort studyAyana Okazaki, Shogo Matsuda, Takuya Kotani, et al.Modern Rheumatology Case Reports|April 2, 2024
Avacopan's potential to decrease MPO-ANCA titres concurrent with ameliorated activity in ANCA-associated vasculitisTomoki Taniguchi, Ryosuke Hiwa, Mikihito Shoji, et al.Frontiers in Immunology|October 17, 2024
Long-term efficacy of mepolizumab in patients with eosinophilic granulomatosis with polyangiitis: a propensity score matching analysis in the multicenter REVEAL cohort studyMayu Shiomi, Ryu Watanabe, Shogo Matsuda, et al.Modern Rheumatology|May 10, 2024
Factors associated with drug retention of mepolizumab in patients with eosinophilic granulomatosis with polyangiitis: A multicentre REVEAL cohort studyMayu Shiomi, Ryu Watanabe, Shogo Matsuda, et al.Modern Rheumatology|June 9, 2025
Safety of glucocorticoid dose reduction in microscopic polyangiitis: a multicentre REVEAL cohort studyHirofumi Miyake, Takuya Kotani, Shogo Matsuda, et al.Frontiers in Immunology|April 20, 2026
Long-term outcomes remain unchanged despite reduced glucocorticoid exposure in ANCA-associated vasculitis: the multicentre REVEAL cohort studyMayu Shiomi, Ryu Watanabe, Muneyuki Hatta, et al.Pageof 2